AI Summary
✦ ClarthaValuation Metrics
Trading 68.0% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.99). Confidence: 72%.
Live forward EPS implies next-12-month EPS of ₹32.65. Applying the stock's normalized valuation corridor produces a fair range of ₹762.70 to ₹1,243.96, with base value near ₹939.99 (+6.8% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹32.65
Forward P/E
26.9x
Base Fair Value
₹939.99
Fair Range
₹762.70 - ₹1,243.96
Upside To Base
+6.8%
Estimate Source
Live forward EPS
Growth Estimate
+12.9%
5Y Average
31.31
Current
48.37
Overvalued
38.10
Undervalued
23.36
5Y Average
17.70
Current
27.34
Overvalued
21.69
Undervalued
13.16
5Y Average
4.45
Current
6.88
Overvalued
5.46
Undervalued
3.31
Peers & Comparison
Sector: Health Care · Theme: Hospitals & Diagnostic Centres
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
RAINBOW CHILDRENS MED LTD RAINBOWHospitals & Diagnostic Centres | +33.2% | 15.7% | 54.4x Fair | -13% vs avg | +1.2% |
PARK MEDI WORLD LIMITED PARKHOSPSHospitals & Diagnostic Centres | +19.3% | 16.1% | 45.8x Undervalued | -27% vs avg | +95.4% |
METROPOLIS HEALTHCARE LTD METROPOLISHospitals & Diagnostic Centres | +16.6% | 11.8% | 58.9x Fair | -6% vs avg | +7.6% |
THYROCARE TECH LTD THYROCAREHospitals & Diagnostic Centres | +24.3% | 20.1% | 54.7x Fair | -12% vs avg | +38.2% |
NARAYANA HRUDAYALAYA LTD. NHHospitals & Diagnostic Centres | +80.4% | 9.0% | 45.4x Undervalued | -27% vs avg | +6.8% |
GLOBAL HEALTH LIMITED MEDANTAHospitals & Diagnostic Centres | +26.5% | 11.9% | 71.4x Fair | +14% vs avg | +6.9% |
VIJAYA DIAGNOSTIC CEN LTD VIJAYAHospitals & Diagnostic Centres | +26.6% | 21.2% | 83.0x Premium | +33% vs avg | +28.0% |
NEPHROCARE HEALTH SERV L NEPHROPLUSHospitals & Diagnostic Centres | +21.2% | 7.7% | 86.7x Premium | +39% vs avg | +48.1% |
YATHARTH HOSP & TRA C S L trades at a discount (50.4x vs peer avg 62.5x), suggesting potential undervaluation relative to the Hospitals & Diagnostic Centres cohort. Peers include RAINBOW CHILDRENS MED LTD, PARK MEDI WORLD LIMITED, METROPOLIS HEALTHCARE LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹158 CrDec 2025Latest net profit
₹23 CrDec 2025Latest EPS
₹2.48Dec 2025Net margin
17.4%Dec 2025Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Dec 2025
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 97.13 | 102 | 110 | 102 | 106 | 119 | 113 | 110 | 112 | 130 | 137 | 158 |
| Expenses | 69.37 | 73.25 | 78.82 | 72.4 | 77.99 | 86.17 | 82.21 | 78.6 | 80.21 | 95.08 | 110 | 122 |
| Operating Profit | 24.01 | 25.93 | 28.13 | 25.36 | 24.45 | 28.79 | 25.89 | 26.62 | 27.07 | 30.37 | 20.64 | 27.54 |
| OPM % | 24.72% | 25.34% | 25.54% | 24.93% | 23.16% | 24.2% | 22.94% | 24.11% | 24.17% | 23.34% | 15.03% | 17.41% |
| Other Income | 0.35 | 0.4 | 3.35 | 4.75 | 5.06 | 2.63 | 1.81 | 3.15 | 4.1 | 7.26 | 6.15 | 5.47 |
| Interest | 2.37 | 2.42 | 1.57 | 0.13 | 0.19 | 0.11 | 0.21 | 0.15 | 0.15 | 0.16 | 0.19 | 0.91 |
| Depreciation | 3.75 | 3.16 | 3.17 | 3.97 | 3.15 | 4 | 4.77 | 5.19 | 4.71 | 4.69 | 6.32 | 9 |
| Profit before tax | 21.99 | 23.91 | 29.91 | 29.98 | 29.32 | 31.31 | 27.49 | 29.62 | 31.02 | 37.47 | 26.6 | 32.1 |
| Tax % | 30.29% | 34.71% | 29.62% | 29.62% | 10.5% | 26.06% | 24.99% | 24.88% | 29.4% | 27.62% | 22.41% | 27.82% |
| Net Profit | 15.33 | 15.61 | 21.05 | 21.1 | 26.24 | 23.15 | 20.62 | 22.25 | 21.9 | 27.12 | 20.64 | 23.17 |
| EPS in Rs | 2.34 | 2.38 | 2.90 | 2.74 | 3.32 | 2.70 | 2.37 | 2.60 | 2.55 | 2.81 | 2.14 | 2.48 |
All values in Rs. Crore unless otherwise stated. Source: CMIE Prowess, Quarterly Interim Standalone.